KaloBios Submits IND Application for Benznidazole to FDA
May 30, 2017 12:20 pm UTC| Business
BRISBANE, Calif., May 30, 2017 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced it has submitted an...
KaloBios Submits IND Application for Benznidazole to FDA
May 30, 2017 12:20 pm UTC| Business
BRISBANE, Calif., May 30, 2017 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced it has submitted an...
KaloBios Submits IND Application for Benznidazole to FDA
May 30, 2017 12:20 pm UTC| Business
BRISBANE, Calif., May 30, 2017 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced it has submitted an...
Qorvo® Boosts Wired Broadband Networks for Superior Video Experience
May 30, 2017 12:20 pm UTC| Business
GREENSBORO, N.C., May 30, 2017 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, has further expanded its CATV portfolio with five new products designed to improve...
KaloBios Submits IND Application for Benznidazole to FDA
May 30, 2017 12:20 pm UTC| Business
BRISBANE, Calif., May 30, 2017 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced it has submitted an...
KaloBios Submits IND Application for Benznidazole to FDA
May 30, 2017 12:20 pm UTC| Business
BRISBANE, Calif., May 30, 2017 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced it has submitted an...
KaloBios Submits IND Application for Benznidazole to FDA
May 30, 2017 12:20 pm UTC| Business
BRISBANE, Calif., May 30, 2017 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced it has submitted an...